Slingshot members are tracking this event:
Xenon Pharmaceuticals expects to file an investigational new drug (IND) application for XEN801 in the first half of 2017 - Discontinued
Slingshot Insights Explained
Mar 24, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Xen801, Ind